ICICI Prudential AMC IPO in Focus as GMP Steady, Subscription & Allotment Watch Intensifies

India’s primary market buzzes as ICICI Prudential AMC IPO subscription heats up and Corona Remedies makes a strong listing debut on December 15, 2025.

ICICI Prudential AMC IPO in Focus as GMP & Subscription Stay in Spotlight

The ICICI Prudential AMC IPO remains a top spotlight issue on December 15, 2025, with updates showing continued traction in both grey market and subscription metrics.

Issue Size: ~₹10,603 crore
Price Band: ₹2,061 – ₹2,165 per share
GMP Trend: Around ~14% premium in grey market — indicating ~₹290+ per share above issue price
Subscription Status (Day 2): Overall ~2.0x subscribed with strong QIB & NII interest; retail still moderate
Allotment Date: Dec 17, 2025
Expected Listing: Dec 19, 2025

Investor focus is on how institutional enthusiasm translates into retail uptake as bidding enters the final day.

“GMP holding firm near double-digit premiums underscores strong belief in AMC’s long-term growth story even before listing.”

Allotment / SME / Upcoming IPO Update

Corona Remedies IPO: Successfully listed today (Dec 15) at a ~38% premium over issue price, debuting around ₹1,470 on NSE / ₹1,452 on BSE vs ₹1,062 IPO price.
Park Medi World IPO: Recently closed; subscription was modest with limited oversubscription signals.
Pajson Agro India IPO (SME): Scheduled to list on Dec 18 with a small positive GMP hint pre-listing.

For real-time updates, check IPO Allotment Status.

Market Context (Short)

Indicator	Status
IPO Sentiment	Positive
GMP Trend	Rising for big issues
Retail Interest	Selective

What Should IPO Investors Watch Next?

GMP movement on Live IPO GMP Today
Final subscription data as bidding closes Dec 16
Allotment date for ICICI Prudential AMC (Dec 17)
Listing performance expectations (Dec 19)

Useful IPO Links & Resources

Disclaimer: IPO investments are subject to market risks. GMP is an unofficial indicator and should not be considered financial advice.